Cigarette Smoke Decreases Airway Epithelial FABP5 Expression and Promotes Pseudomonas aeruginosa Infection

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Gally, Fabienne ^a   Chu, Hong Wei ^a   Bowler, Russell P ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CIGARETTE SMOKE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; INTERLEUKIN 8; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SHORT HAIRPIN RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL LOAD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FABP5 GENE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GENE OVEREXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOREACTIVITY; INFECTION PREVENTION; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; SMOKING;

BACTERIAL LOAD; BRONCHI; CYTOKINES; DOWN-REGULATION; EPITHELIAL CELLS; FATTY ACID-BINDING PROTEINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNITY, INNATE; PPAR GAMMA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; TOBACCO PRODUCTS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 84872784527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051784     Document Type: Article

References (45)

1. Chung KF, Adcock IM, (2008) Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 31: 1334-1356.
2. Fabbri L, Pauwels RA, Hurd SS, (2004) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003. COPD 1: 105-141 discussion 103-104.
3. Martin RJ, Wexler RB, Day BJ, Harbeck RJ, Pinkerton KE, et al. (2006) Interaction between cigarette smoke and mycoplasma infection: a murine model. COPD 3: 3-8.
4. Martinez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL, (2008) Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 47: 1526-1533.
5. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, et al. (1999) Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 14: 1015-1022.
6. Rosell A, Monso E, Soler N, Torres F, Angrill J, et al. (2005) Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 165: 891-897.
7. Iyer Parameswaran G, Murphy TF, (2009) Chronic obstructive pulmonary disease: role of bacteria and updated guide to antibacterial selection in the older patient. Drugs Aging 26: 985-995.
8. Sethi S, Murphy TF, (2008) Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359: 2355-2365.
9. Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, et al. (2008) Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 853-860.
10. Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, et al. (1999) Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 116: 40-46.
11. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, et al. (1998) Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 113: 1542-1548.
12. Lode H, Allewelt M, Balk S, De Roux A, Mauch H, et al. (2007) A prediction model for bacterial etiology in acute exacerbations of COPD. Infection 35: 143-149.
13. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
14. Bals R, Hiemstra PS, (2004) Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 23: 327-333.
15. Polosukhin VV, Cates JM, Lawson WE, Zaynagetdinov R, Milstone AP, et al. (2011) Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 184: 317-327.
16. Puchelle E, Zahm JM, Tournier JM, Coraux C, (2006) Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 3: 726-733.
17. Green RM, Gally F, Keeney JG, Alper S, Gao B, et al. (2009) Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model. PLoS One 4: e6860.
18. Zimmerman AW, Veerkamp JH, (2001) Fatty-acid-binding proteins do not protect against induced cytotoxicity in a kidney cell model. Biochem J 360: 159-165.
19. Siegenthaler G, Hotz R, Chatellard-Gruaz D, Didierjean L, Hellman U, et al. (1994) Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro. Biochem J 302 (Pt 2):: 363-371.
20. Chu HW, Gally F, Thaikoottathil J, Janssen-Heininger YM, Wu Q, et al. (2010) SPLUNC1 regulation in airway epithelial cells: role of Toll-like receptor 2 signaling. Respiratory research 11: 155.
21. Phillips J, Kluss B, Richter A, Massey E, (2005) Exposure of bronchial epithelial cells to whole cigarette smoke: assessment of cellular responses. Alternatives to laboratory animals: ATLA 33: 239-248.
22. Baqir M, Chen CZ, Martin RJ, Thaikoottathil J, Case SR, et al. (2008) Cigarette smoke decreases MARCO expression in macrophages: implication in Mycoplasma pneumoniae infection. Respir Med 102: 1604-1610.
23. Wu Q, Martin RJ, Rino JG, Jeyaseelan S, Breed R, et al. (2007) A deficient TLR2 signaling promotes airway mucin production in Mycoplasma pneumoniae-infected allergic mice. Am J Physiol Lung Cell Mol Physiol 292: L1064-1072.
24. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF, (1998) A family of human receptors structurally related to Drosophila Toll. Proceedings of the National Academy of Sciences of the United States of America 95: 588-593.
25. Vora P, Youdim A, Thomas LS, Fukata M, Tesfay SY, et al. (2004) Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. Journal of immunology 173: 5398-5405.
26. Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, et al. (2010) Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proceedings of the National Academy of Sciences of the United States of America 107: 8772-8777.
27. Holt PG, Keast D, (1977) Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriological reviews 41: 205-216.
28. Sopori M, (2002) Effects of cigarette smoke on the immune system. Nature reviews Immunology 2: 372-377.
29. Mahanonda R, Sa-Ard-Iam N, Eksomtramate M, Rerkyen P, Phairat B, et al. (2009) Cigarette smoke extract modulates human beta-defensin-2 and interleukin-8 expression in human gingival epithelial cells. Journal of periodontal research 44: 557-564.
30. Janssens W, Nuytten H, Dupont LJ, Van Eldere J, Vermeire S, et al. (2010) Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 182: 163-169.
31. Jiang C, Ting AT, Seed B, (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
32. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK, (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82.
33. Babaev VR, Runner RP, Fan D, Ding L, Zhang Y, et al. (2011) Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-gamma-regulated genes. Arteriosclerosis, thrombosis, and vascular biology 31: 1283-1290.
34. Greene CM, Carroll TP, Smith SG, Taggart CC, Devaney J, et al. (2005) TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. Journal of immunology 174: 1638-1646.
35. Travassos LH, Carneiro LA, Girardin SE, Boneca IG, Lemos R, et al. (2005) Nod1 participates in the innate immune response to Pseudomonas aeruginosa. The Journal of biological chemistry 280: 36714-36718.
36. Birchler T, Seibl R, Buchner K, Loeliger S, Seger R, et al. (2001) Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. European journal of immunology 31: 3131-3137.
37. Boughan PK, Argent RH, Body-Malapel M, Park JH, Ewings KE, et al. (2006) Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. The Journal of biological chemistry 281: 11637-11648.
38. Feingold KR, Kazemi MR, Magra AL, McDonald CM, Chui LG, et al. (2010) ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists. Atherosclerosis 209: 81-88.
39. Maeda K, Uysal KT, Makowski L, Gorgun CZ, Atsumi G, et al. (2003) Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 52: 300-307.
40. Makowski L, Hotamisligil GS, (2005) The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Current opinion in lipidology 16: 543-548.
41. Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, et al. (2005) Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell metabolism 1: 107-119.
42. Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, et al. (2004) Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 110: 1492-1498.
43. Hong J, Gu W, Zhang Y, Yan Q, Dai M, et al. (2011) Different association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adults. Atherosclerosis 217: 194-200.
44. Yeung DC, Wang Y, Xu A, Cheung SC, Wat NM, et al. (2008) Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis. European heart journal 29: 2156-2163.
45. Naveed B, Weiden MD, Kwon S, Gracely EJ, Comfort AL, et al. (2012) Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study. American journal of respiratory and critical care medicine 185: 392-399.